You are here

PotNetwork Holdings’ Diamond CBD’s Meds Biotech Line Expands With Heighted Demand for Its New CBD and “CBD & Tumeric” Supplements

June 08, 2018

PotNetwork Holding Inc. is pleased to announced that its subsidiary, Diamond CBD, Inc., has been experiencing heightened channel and consumer interest in, and sales of, its recently introduced Meds Biotech CBD-infused product line. 

Made from organic industrial hemp and THC free, these Meds Biotech supplements are formulated with a combination of 10mg of CBD combined with a turmeric blend that delivers 750mg of bioactive turmeric per capsule. To view these products, visit: the CBD Capsules collection.

Hemp capsules deliver the natural benefits of CBD hemp oil in convenient pill-capsule form. Encapsulation enables CBD and associated natural compounds and nutrients found in hemp oil to be absorbed readily in the digestive system. CBD, or cannabidiol, is among the most abundant of the more than 100 cannabinoids found in all cannabis plants, including hemp. Like all cannabinoids, CBD interacts with our body’s systems to provide a broad range of health benefits. 

Meds Biotech, as a wellness focused new product line, expands the Company’s marketing and distribution into targeted health-focused distribution channels, such as vitamin shops, health product stores, gyms and fitness centers, chiropractic and physicians’ offices. The Company regards these resale venues collectively as a new industry sector for  specialized product lines.

According to the Huffington Post, “CBD is a powerful anti-epileptic, anti-depressant, anti-inflammatory, anti-nauseate, sleep aid, muscle relaxant, sedative and anti-proliferative.” When combined with the benefits of Turmeric, effectiveness is shown to be enhanced substantially. 

According to https://www.ncbi.nlm.nih.gov “Turmeric is used as an herbal medicine for rheumatoid arthritis, chronic anterior uveitis, conjunctivitis, skin cancer, small pox, chicken pox, wound healing, urinary tract infections, and liver ailments (Dixit, Jain, and Joshi 1988). It is also used for digestive disorders; to reduce flatus, jaundice, menstrual difficulties, and colic; for abdominal pain and distension (Bundy et al. 2004); and for dyspeptic conditions including loss of appetite, postprandial feelings of fullness, and liver and gallbladder complaints. It has anti-inflammatory, choleretic, antimicrobial, and carminative actions (Mills and Bone 2000).”

About Diamond CBD Inc.: Diamond CBD focuses on the research, development, and multinational marketing of premium hemp extracts that contain a broad range of cannabinoids and natural hemp derivatives. Diamond CBD’s team consists of hemp industry pioneers and natural product experts, chemists, doctors and scientists, dedicated to producing the finest and purest cannabidiol (CBD) oils. The result is a robust selection considered among the most powerful natural CBD oils, tinctures, edibles, and vape liquids found anywhere. For more information, please visit its website at www.DiamondCBD.com.

About PotNetwork Holdings, Inc: PotNetwork Holding, Inc. (OTC Pink:POTN) is a publicly traded company that acts as a holding company for its subsidiaries, First Capital Venture Co., the owner of Diamond CBD, Inc., the maker of Diamond CBD oils.

Safe Harbor Act: Forward-Looking Statements are included within the meaning of Section 27A of the Securities Act of 1933, and Section 21E of the Securities Exchange Act of 1934, as amended. All statements regarding our expected future financial position, results of operations, cash flows, financing plans, business strategy, products and services, competitive positions, growth opportunities, plans and objectives of management for future operations, including words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and similar expressions are forward-looking statements and involve risks, uncertainties and contingencies, many of which are beyond our control, which may cause actual results, performance, or achievements to differ materially from anticipated results, performance, or achievements. We are under no obligation to (and expressly disclaim any such obligation to) update or alter forward-looking statements, whether as a result of new information, future events or otherwise.